Therapeutic Effects of Berberine against Urological Cancers: Biological Potentials Based on Cellular Mechanisms
- PMID: 37933211
- DOI: 10.2174/0115665240263630231009050436
Therapeutic Effects of Berberine against Urological Cancers: Biological Potentials Based on Cellular Mechanisms
Abstract
Background: Urological cancers, encompassing prostate, kidney, and bladder cancers, pose significant global health challenges. Current treatment modalities, including chemotherapy, radiotherapy, and surgery, individually or in combination, have limitations in efficacy and are associated with notable morbidity and mortality.
Methods: This review explores alternative therapeutic avenues, emphasizing the exploration of natural compounds, with a specific focus on berberine. Berberine's potential as a treatment for urological cancers is investigated through an extensive examination of cellular and molecular mechanisms.
Results: The comprehensive analysis reveals promising anticancer properties associated with berberine, substantiated by a wealth of experimental studies. The agent's impact on urological cancers is discussed, highlighting notable findings related to its efficacy and safety profile.
Conclusions: Given the high mortality rates and potential side effects associated with current standard treatments for urological cancers, the exploration of alternative, effective, and safer options is imperative. This review underscores berberine's therapeutic potential, shedding light on its anticancer effects and encouraging further research in the pursuit of enhanced treatment strategies.
Keywords: Berberine; apoptosis.; bladder cancer; oxidative stress; prostate cancer; renal cell carcinoma; urological cancer.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
A Comprehensive Review Highlighting the Prospects of Phytonutrient Berberine as an Anticancer Agent.J Biochem Mol Toxicol. 2025 Jan;39(1):e70073. doi: 10.1002/jbt.70073. J Biochem Mol Toxicol. 2025. PMID: 39717894 Review.
-
Berberine: A multifaceted agent for lung cancer treatment-from molecular insight to clinical applications.Gene. 2025 Jan 20;934:149021. doi: 10.1016/j.gene.2024.149021. Epub 2024 Oct 19. Gene. 2025. PMID: 39427827 Review.
-
Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects.Life Sci. 2022 Nov 15;309:120984. doi: 10.1016/j.lfs.2022.120984. Epub 2022 Sep 20. Life Sci. 2022. PMID: 36150461 Review.
-
Targeting autophagy in urological system cancers: From underlying mechanisms to therapeutic implications.Biochim Biophys Acta Rev Cancer. 2024 Nov;1879(6):189196. doi: 10.1016/j.bbcan.2024.189196. Epub 2024 Oct 18. Biochim Biophys Acta Rev Cancer. 2024. PMID: 39426690 Review.
-
Unveiling the therapeutic potential of berberine: its therapeutic role and molecular mechanisms in kidney diseases.Front Pharmacol. 2025 Feb 21;16:1549462. doi: 10.3389/fphar.2025.1549462. eCollection 2025. Front Pharmacol. 2025. PMID: 40061955 Free PMC article. Review.
References
-
- Schulz W.A.; Sørensen K.D.; Epigenetics of urological cancers. In: MDPI 2019,4775
-
- Bazrafshani M.S.; Pardakhty A.; Khandani B.K.; Tajadini H.; Pour S.G.; Hashemi S.; The prevalence and predictors of herb-drug interactions among Iranian cancer patients during chemotherapy courses. Authorea 2022,2022,33790946 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources